NAD+ IV Therapy: What Current Research Says About Its Role in Longevity

NAD+ IV therapy is one of the more heavily marketed additions to longevity clinics, often described in terms of energy, cellular repair, and anti-aging. Given how much marketing language surrounds it, it's worth looking directly at what the research base actually supports before discussing it as part of any protocol.

What NAD+ is

Nicotinamide adenine dinucleotide (NAD+) is a molecule involved in core cellular energy production and DNA repair processes. NAD+ levels are understood to decline with age, which is the biological premise behind interest in restoring them through supplementation or infusion.

What a recent systematic review found

A PRISMA-guided systematic review of preclinical and clinical evidence on NAD+ supplementation for anti-aging and wellness examined 113 intervention studies — 33 in humans and 80 in rodent models. Its findings are more measured than most marketing material: no eligible outcomes trials specifically tested intravenous or intramuscular NAD+ for anti-aging or wellness purposes. For oral precursor forms (nicotinamide riboside and nicotinamide mononucleotide), human studies generally showed increases in blood or cellular NAD-related markers, but results on outcomes people actually care about — physical performance, insulin sensitivity, arterial stiffness, sleep quality — were mixed, with many studies finding no clear effect.

The review also notes that NAD+ is not FDA-approved for anti-aging or wellness use, and that there is no universally accepted clinical guideline defining standardized dosing or long-term safety specifically for wellness-oriented NAD+ therapy. Separately, an early human pilot study on IV administration specifically has suggested that NAD+ infusions may be inefficient at meaningfully raising intracellular NAD+ levels — a mechanistic question distinct from, but relevant to, the outcomes question above.

Where the evidence is stronger

This isn't a case of zero evidence anywhere. The review identifies the strongest existing clinical evidence for NAD+-related therapy in the context of opioid and alcohol withdrawal, a different clinical use case from longevity or wellness. For general anti-aging and longevity applications specifically, the review describes benefits as mechanistically plausible — meaning there's a biological rationale worth studying — but not yet confirmed by large randomized trials in humans.

What this means for how the topic is discussed

Given this evidence picture, cautious language is the accurate language, not just a legal formality. NAD+ IV therapy is reasonably described as an area of ongoing research with a plausible biological rationale and a generally favorable short-term safety profile in supervised settings — not as a proven longevity intervention with established outcomes. A physician-directed longevity consultation should reflect that same honesty rather than presenting NAD+ as a settled science.

At StemCellor, NAD+ IV therapy is one protocol that may be discussed after a biological-age diagnostics panel and physician review, alongside other longevity-focused options — never as a standalone starting point. Our Biological Age Diagnostics & Longevity Therapy page explains how this fits into a full consultation, and our Metabolic Health page covers a common starting concern for patients considering this path. Our Safety & Regulation overview explains the broader regulatory framework longevity protocols in Japan are coordinated within.

Frequently asked questions

Is NAD+ IV therapy proven to slow aging?

No. A recent systematic review found no eligible outcomes trials specifically testing IV or intramuscular NAD+ for anti-aging or wellness in humans. The biological rationale is plausible, but large-scale confirmed evidence isn't there yet.

Is NAD+ IV therapy FDA-approved for longevity?

No. Current research indicates it is not FDA-approved for anti-aging or wellness use, and there is no universally accepted clinical guideline for wellness-oriented dosing.

Is it safe?

Short-term use under supervised, sterile conditions has generally shown favorable tolerability in the studies reviewed, without consistent serious safety signals reported in randomized studies. That is a safety observation, not a claim about effectiveness for longevity outcomes.

References

Gallagher C, Emmanuel OO. "NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence." Ageing Research Reviews. 2026. DOI: 10.1016/j.arr.2026.103057